BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24028602)

  • 1. Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition.
    Whipple RA; Vitolo MI; Boggs AE; Charpentier MS; Thompson K; Martin SS
    Breast Cancer Res; 2013; 15(5):R83. PubMed ID: 24028602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parthenolide inhibits tubulin carboxypeptidase activity.
    Fonrose X; Ausseil F; Soleilhac E; Masson V; David B; Pouny I; Cintrat JC; Rousseau B; Barette C; Massiot G; Lafanechère L
    Cancer Res; 2007 Apr; 67(7):3371-8. PubMed ID: 17409447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement.
    Whipple RA; Matrone MA; Cho EH; Balzer EM; Vitolo MI; Yoon JR; Ioffe OB; Tuttle KC; Yang J; Martin SS
    Cancer Res; 2010 Oct; 70(20):8127-37. PubMed ID: 20924103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vimentin filaments support extension of tubulin-based microtentacles in detached breast tumor cells.
    Whipple RA; Balzer EM; Cho EH; Matrone MA; Yoon JR; Martin SS
    Cancer Res; 2008 Jul; 68(14):5678-88. PubMed ID: 18632620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of tubulin detyrosination by parthenolide recruits the plant-specific kinesin KCH to cortical microtubules.
    Schneider N; Ludwig H; Nick P
    J Exp Bot; 2015 Apr; 66(7):2001-11. PubMed ID: 25779700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costunolide, a Sesquiterpene Lactone, Suppresses Skin Cancer via Induction of Apoptosis and Blockage of Cell Proliferation.
    Lee SH; Cho YC; Lim JS
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in silico evaluation of NF-κB targeted costunolide action on estrogen receptor-negative breast cancer cells--a comparison with normal breast cells.
    Pitchai D; Roy A; Banu S
    Phytother Res; 2014 Oct; 28(10):1499-505. PubMed ID: 24733523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
    Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
    Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microtubule-interfering activity of parthenolide.
    Miglietta A; Bozzo F; Gabriel L; Bocca C
    Chem Biol Interact; 2004 Oct; 149(2-3):165-73. PubMed ID: 15501437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.
    Oka D; Nishimura K; Shiba M; Nakai Y; Arai Y; Nakayama M; Takayama H; Inoue H; Okuyama A; Nonomura N
    Int J Cancer; 2007 Jun; 120(12):2576-81. PubMed ID: 17290398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitization in non-small cell lung cancer cells by IKK inhibitor occurs via NF-kappaB and mitochondrial cytochrome c cascade.
    Jin X; Qiu L; Zhang D; Zhang M; Wang Z; Guo Z; Deng C; Guo C
    J Cell Mol Med; 2009; 13(11-12):4596-607. PubMed ID: 19067767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of NF-κB activation in matrix metalloproteinase 9, vascular endothelial growth factor and interleukin 8 expression and secretion in human breast cancer cells.
    Li C; Guo S; Shi T
    Cell Biochem Funct; 2013 Apr; 31(3):263-8. PubMed ID: 23086737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local anesthetics inhibit kinesin motility and microtentacle protrusions in human epithelial and breast tumor cells.
    Yoon JR; Whipple RA; Balzer EM; Cho EH; Matrone MA; Peckham M; Martin SS
    Breast Cancer Res Treat; 2011 Oct; 129(3):691-701. PubMed ID: 21069453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT.
    Nakshatri H; Appaiah HN; Anjanappa M; Gilley D; Tanaka H; Badve S; Crooks PA; Mathews W; Sweeney C; Bhat-Nakshatri P
    Cell Death Dis; 2015 Jan; 6(1):e1608. PubMed ID: 25611383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel efficacy is increased by parthenolide via nuclear factor-kappaB pathways in in vitro and in vivo human non-small cell lung cancer models.
    Gao ZW; Zhang DL; Guo CB
    Curr Cancer Drug Targets; 2010 Nov; 10(7):705-15. PubMed ID: 20578985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells.
    Kishida Y; Yoshikawa H; Myoui A
    Clin Cancer Res; 2007 Jan; 13(1):59-67. PubMed ID: 17200339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sesquiterpene lactone parthenolide markedly enhances sensitivity of human A549 cells to low-dose oxaliplatin via inhibition of NF-kappaB activation and induction of apoptosis.
    Fang LJ; Shao XT; Wang S; Lu GH; Xu T; Zhou JY
    Planta Med; 2010 Feb; 76(3):258-64. PubMed ID: 19774508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen Peroxide Induces α-Tubulin Detyrosination and Acetylation and Impacts Breast Cancer Metastatic Phenotypes.
    Stemberger MB; Ju JA; Thompson KN; Mathias TJ; Jerrett AE; Chang KT; Ory EC; Annis DA; Mull ML; Gilchrist DE; Vitolo MI; Martin SS
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parthenolide Destabilizes Microtubules by Covalently Modifying Tubulin.
    Hotta T; Haynes SE; Blasius TL; Gebbie M; Eberhardt EL; Sept D; Cianfrocco M; Verhey KJ; Nesvizhskii AI; Ohi R
    Curr Biol; 2021 Feb; 31(4):900-907.e6. PubMed ID: 33482110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation.
    Kim SL; Kim SH; Park YR; Liu YC; Kim EM; Jeong HJ; Kim YN; Seo SY; Kim IH; Lee SO; Lee ST; Kim SW
    Mol Cancer Res; 2017 Feb; 15(2):141-151. PubMed ID: 28108625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.